Gagliardi Mario, Oliviero Giovanni, Fusco Michele, Napoli Marco, Sica Andrea, Maurano Attilio, Sica Mariano, Zulli Claudio
Digestive Endoscopy Unit, University Hospital "San Giovanni di Dio e Ruggi d'Aragona," Salerno, Italy.
Digestive Surgical Endoscopy Unit, Polyclinic "Agostino Gemelli" Foundation, Rome, Italy.
ACG Case Rep J. 2022 Jan 6;9(1):e00744. doi: 10.14309/crj.0000000000000744. eCollection 2022 Jan.
Endoscopic sphincterotomy (ES) is commonly performed during endoscopic retrograde cholangiopancreatography, and bleeding is a severe adverse event. PuraStat is a peptide developed as a hemostatic agent for endoscopy. We report its use as a hemostatic strategy in post-ES bleeding refractory to combined hemostasis. A patient with choledocholithiasis underwent endoscopic retrograde cholangiopancreatography for stone removal. After the ES, severe bleeding refractory to the injection of diluted epinephrine around the bleeding source and metal stent placement occurred. Hemostasis was achieved with the application of the hemostatic gel. We reported the use of novel self-assembling hemostatic gel as an effective therapeutic tool for post-ES refractory bleeding.
内镜括约肌切开术(ES)通常在内镜逆行胰胆管造影术期间进行,出血是一种严重的不良事件。PuraStat是一种开发用作内镜止血剂的肽。我们报告了其作为联合止血难治性ES后出血的止血策略的应用。一名胆总管结石患者接受了内镜逆行胰胆管造影术以取出结石。ES后,在出血源周围注射稀释肾上腺素和放置金属支架均无法控制严重出血。应用止血凝胶实现了止血。我们报告了使用新型自组装止血凝胶作为ES后难治性出血的有效治疗工具。